5'-IODO-5'-DEOXYTHYMIDINE manufacturers
|
| | 5'-IODO-5'-DEOXYTHYMIDINE Basic information |
| Product Name: | 5'-IODO-5'-DEOXYTHYMIDINE | | Synonyms: | 5'-IODO-5'-DEOXYTHYMIDINE;5'-Deoxy-5'-iodo-D-thymidine;5'-Deoxy-5'-iodothymidine;1-((2R,4S,5S)-4-hydroxy-5-(iodomethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione;Thymidine, 5'-deoxy-5'-iodo-;1-[4-HYDROXY-5-(IODOMETHYL)OXOLAN-2-YL]-5-METHYL-3H-PYRIMIDINE-2,4-DIONE;5’-Deoxy-5’-iodothymidine | | CAS: | 25953-14-4 | | MF: | C10H13IN2O4 | | MW: | 352.13 | | EINECS: | | | Product Categories: | | | Mol File: | 25953-14-4.mol |  |
| | 5'-IODO-5'-DEOXYTHYMIDINE Chemical Properties |
| | 5'-IODO-5'-DEOXYTHYMIDINE Usage And Synthesis |
| Uses | 5′-Deoxy-5′-iodothymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 5'-IODO-5'-DEOXYTHYMIDINE Preparation Products And Raw materials |
|